In the original version of this article (1), the Introduction provides an incorrect false-positive rate of lung cancer screening with low-dose computed tomography (CT) as reported in the National Lung Screening Trial (NLST) results. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
References
1.
Lou
T-F
, Sethuraman
D
, Dospoy
P
, Srivastva
P
, Kim
HS
, Kim
J
, et al Cancer-specific production of N-acetylaspartate via NAT8L overexpression in non–small cell lung cancer and its potential as a circulating biomarker
. Cancer Prev Res
2016
;9
:43
–52
.©2019 American Association for Cancer Research.
2019
American Association for Cancer Research.